Company Website

Contacts

Melissa Wilmer
-Leukemia
mwilmer@amgen.com
319-830-5681

Jennifer DeGrave
-Multiple Myeloma
jdegrave@amgen.com
612-210-7216

Virtual Exhibit Hall Home

Amgen Hematology represents products in both Acute Lymphoblastic Leukemia and Multiple Myeloma. Please contact Melissa Wilmer with questions regarding immunotherapy in the treatment of ALL patients who are MRD+, relapsed, or refractory to chemotherapy and Jen DeGrave for questions regarding the selective proteasome inhibitor used to treat Multiple Myeloma.